Perioperative Immunotherapy for NSCLC (ECTOP-1030)

NCT06572722 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This trial has not been initiated

Conditions

Lung Cancer

Interventions

DRUG: Atezolizumab
DRUG: Nivolumab
DRUG: Pembrolizumab

Sponsor

Fudan University